Biopharma | January 11, 2026
Prokaryotics and Basilea team up to tackle deadly fungal infections
The partnership aims to develop a first-in-class broad-spectrum antifungal to combat life-threatening invasive infections
The partnership aims to develop a first-in-class broad-spectrum antifungal to combat life-threatening invasive infections
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
The receipt of this order further strengthens the company's position in the global pharmaceutical market
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Inclacumab was generally well tolerated in THRIVE-131
A new weapon in the global fight against malaria
Subscribe To Our Newsletter & Stay Updated
